Head-to-head · WeighScore
BetterMe Rx vs Mevo Health
The verdict
BetterMe Rx takes it — 64.9/100 to 60.2/100.
BetterMe Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BetterMe Rx offers compounded semaglutide ($199/mo) and tirzepatide ($299/mo) in both injectable and oral daily tablet formats.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | BetterMe Rx | Mevo Health |
|---|---|---|
| WeighScore | 64.9/100 | 60.2/100 |
| Grade | C | C |
| Scorecard rank | #230 | #326 |
| Semaglutide | $199/mo (promotional rate, compounded) | $199/mo (all doses, compounded) |
| Tirzepatide | $299/mo (promotional rate, compounded) | $259/mo (all doses, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #230 · C
Strengths
- LegitScript verified
- All 50 states coverage
- Six named pharmacy partners with phone numbers — exceptional transparency
- Both injectable and oral daily tablet formats for sema and tirz
- Multi-month discounts (3-month and 6-month plans)
Where it loses points
- No formal corporate entity name or address disclosed
- Compounded only — no brand-name options
- Broader platform (HRT, ED, NAD+, Sermorelin, skincare)
- Headline $199/$299 are limited-time SALE prices; regular prices are $249/$349 per month
Graded #326 · C
Strengths
- LegitScript verification badge on multiple pages
- Publishes the FDA compounded-medication disclaimer
- Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
- Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
- Public entry-level pricing surfaced
Where it loses points
- States served not listed on any public page
- Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
- No formal Medical Director role disclosed
- Only 'as low as' entry pricing shown — no per-dose itemization
- No SOC 2 certification claimed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.